US Markets
AZN

AstraZeneca, Oxford allowed to resume COVID-19 vaccine trial in U.S. - WSJ

Credit: REUTERS/DADO RUVIC

Federal health regulators have decided to allow the resumption of U.S. studies of a leading COVID-19 vaccine candidate from AstraZeneca Plc and the University of Oxford, the Wall Street Journal reported on Friday, citing people familiar with the matter. (Reporting by Munsif Vengattil; Editing by Maju Samuel) ((munsif.vengattil@thomsonreuters.com;)) nL4N2HE42L

Oct 23 (Reuters) - Federal health regulators have decided to allow the resumption of U.S. studies of a leading COVID-19 vaccine candidate from AstraZeneca Plc AZN.L and the University of Oxford, the Wall Street Journal reported on Friday, citing people familiar with the matter.

(Reporting by Munsif Vengattil; Editing by Maju Samuel)

((munsif.vengattil@thomsonreuters.com;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

AZN

Latest US Markets Videos

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More